These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26159201)

  • 21. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.
    Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B
    Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.
    Kauwe JS; Jacquart S; Chakraverty S; Wang J; Mayo K; Fagan AM; Holtzman DM; Morris JC; Goate AM
    Ann Neurol; 2007 May; 61(5):446-53. PubMed ID: 17366635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
    Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.
    Jiao B; Tang B; Liu X; Xu J; Wang Y; Zhou L; Zhang F; Yan X; Zhou Y; Shen L
    Neurobiol Aging; 2014 Aug; 35(8):1957.e1-6. PubMed ID: 24650794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient with early-onset Alzheimer's disease with a novel PSEN1 p.Leu424Pro mutation.
    Guven G; Erginel-Unaltuna N; Samanci B; Gulec C; Hanagasi H; Bilgic B
    Neurobiol Aging; 2019 Dec; 84():238.e1-238.e4. PubMed ID: 31296348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease.
    Vo VG; Pyun JM; Bagyinszky E; An SSA; Kim SY
    Curr Alzheimer Res; 2020; 17(5):438-445. PubMed ID: 32589559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain.
    Monti N; Cavallaro RA; Stoccoro A; Nicolia V; Scarpa S; Kovacs GG; Fiorenza MT; Lucarelli M; Aronica E; Ferrer I; Coppedè F; Troen AM; Fuso A
    Epigenetics; 2020 Aug; 15(8):781-799. PubMed ID: 32019393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of APOE Christchurch variant in five age of onset outliers with PSEN1, PSEN2 Alzheimer's disease and MAPT frontotemporal dementia.
    Yu CE; Chen S; Jayadev S; Bird T
    J Neurol Sci; 2020 Nov; 418():117143. PubMed ID: 32977230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?
    Larner AJ
    Epilepsy Behav; 2011 May; 21(1):20-2. PubMed ID: 21501974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia.
    Testi S; Peluso S; Fabrizi GM; Antenora A; Russo CV; Pappatà S; Padovani A; Ferrarini M; Filla A
    J Alzheimers Dis; 2014; 41(3):709-14. PubMed ID: 24718101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation.
    Gu X; Chu T; Liu L; Han X
    Clin Neurol Neurosurg; 2019 Feb; 177():47-53. PubMed ID: 30599314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer's disease.
    Roeber S; Müller-Sarnowski F; Kress J; Edbauer D; Kuhlmann T; Tüttelmann F; Schindler C; Winter P; Arzberger T; Müller U; Danek A; Kretzschmar HA
    J Neural Transm (Vienna); 2015 Dec; 122(12):1715-9. PubMed ID: 26350633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease.
    Dermaut B; Roks G; Theuns J; Rademakers R; Houwing-Duistermaat JJ; Serneels S; Hofman A; Breteler MM; Cruts M; Van Broeckhoven C; van Duijn CM
    J Neurol; 2001 Nov; 248(11):935-9. PubMed ID: 11757955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis.
    Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR
    Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very early-onset sporadic Alzheimer's disease with a de novo mutation in the PSEN1 gene.
    Lou F; Luo X; Li M; Ren Y; He Z
    Neurobiol Aging; 2017 May; 53():193.e1-193.e5. PubMed ID: 28131463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.
    Van Giau V; Pyun JM; Suh J; Bagyinszky E; An SSA; Kim SY
    BMC Neurol; 2019 Aug; 19(1):188. PubMed ID: 31391004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.
    Larner AJ; Doran M
    J Alzheimers Dis; 2009; 17(2):259-65. PubMed ID: 19221408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.